Prostate Cancer Coverage from Every Angle

Hannah L. Rush, MBChB, on Self-Reported Quality of Life in the STAMPEDE Trial

Posted: Tuesday, March 3, 2020

Hannah L. Rush, MBChB, of the Clinical Trials Unit at University College London, discusses data on comparative self-reported quality of life and symptoms, as well as what the literature shows about the adverse events associated with docetaxel vs abiraterone.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.